Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05216120
Title Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors HonorHealth Research Institute
Indications

pancreatic adenosquamous carcinoma

Therapies

Pemigatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST